Literature DB >> 22526441

Expression of AMPA receptor subunits in hippocampus after status convulsion.

Yue Hu1, Li Jiang, Hengsheng Chen, XiaoPing Zhang.   

Abstract

OBJECTIVE: The expression of 2-amino-3-(5-methyl-3-oxo-1, 2-oxazol-4-yl) propanoic acid receptor (AMPAR) subunits in the hippocampus of naive immature and adult rats (IRs, ARs) was investigated after status convulsion (SC).
METHODS: Seizures were induced in IRs and ARs with intraperitoneal injections of lithium and pilocarpine. Rats were killed at four time points (3 h, 1 day, 3 days, and 7 days) after SC. The proportion of apoptotic cells was quantified by Annexin V-FITC apoptosis detection. The location and type of apoptotic cells were assessed by using terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling staining. Immunoblotting techniques were used to demonstrate changes in AMPAR subunit expression.
RESULTS: Severe seizures induced neuronal apoptosis in the hippocampus. The proportion of apoptotic cells in IRs was consistently lower than that in ARs after SC. The expressions of four AMPAR subunits in IRs were consistently lower than those in ARs before and after SC. SC for 1 h inhibited the expression of glutamate receptors (GluR1-4) in the hippocampus of IRs and ARs and altered the subunit composition of AMPARs. GluR2 was the predominant AMPAR subunit in the hippocampus of normal ARs, while the GluR2/3 subunits were predominantly expressed 7 days after SC. GluR3/4 subunits were mainly expressed in the hippocampus of normal IRs, which had the lowest levels of GluR2.
CONCLUSIONS: Immature brain was more resistant to seizure-induced neural damage. The time course of reduction and recovery differed for each subunit and was dependent on developmental stage. The increased expression of GluR2 could confer early but transient protection in the immature brain after SC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526441     DOI: 10.1007/s00381-012-1747-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  26 in total

Review 1.  Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus.

Authors:  Karthik Rajasekaran; Santina A Zanelli; Howard P Goodkin
Journal:  Semin Pediatr Neurol       Date:  2010-09       Impact factor: 1.636

2.  Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses.

Authors:  Qiang Zhou; Koichi J Homma; Mu-ming Poo
Journal:  Neuron       Date:  2004-12-02       Impact factor: 17.173

3.  Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins.

Authors:  Guillermo M Elias; Lars Funke; Valentin Stein; Seth G Grant; David S Bredt; Roger A Nicoll
Journal:  Neuron       Date:  2006-10-19       Impact factor: 17.173

Review 4.  Calcium: a role for neuroprotection and sustained adaptation.

Authors:  Linda K Friedman
Journal:  Mol Interv       Date:  2006-12

5.  Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons.

Authors:  R J Wenthold; R S Petralia; I I Blahos J; A S Niedzielski
Journal:  J Neurosci       Date:  1996-03-15       Impact factor: 6.167

6.  Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting.

Authors:  M D Ehlers
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

7.  Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures.

Authors:  R M Sanchez; S Koh; C Rio; C Wang; E D Lamperti; D Sharma; G Corfas; F E Jensen
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

8.  Age-dependent consequences of status epilepticus: animal models.

Authors:  Morris H Scantlebury; James G Heida; Henry J Hasson; Jana Velísková; Libor Velísek; Aristea S Galanopoulou; Solomon L Moshé
Journal:  Epilepsia       Date:  2007       Impact factor: 5.864

9.  Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures.

Authors:  Sanjay N Rakhade; Chengwen Zhou; Paven K Aujla; Rachel Fishman; Nikolaus J Sucher; Frances E Jensen
Journal:  J Neurosci       Date:  2008-08-06       Impact factor: 6.167

10.  Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466.

Authors:  Brita Fritsch; Jeffrey J Stott; Joy Joelle Donofrio; Michael A Rogawski
Journal:  Epilepsia       Date:  2009-07-20       Impact factor: 5.864

View more
  4 in total

1.  AMPA receptor properties are modulated in the early stages following pilocarpine-induced status epilepticus.

Authors:  Isabella Russo; Daniela Bonini; Luca La Via; Sergio Barlati; Alessandro Barbon
Journal:  Neuromolecular Med       Date:  2013-03-15       Impact factor: 3.843

2.  Neuroprotective activity of parawixin 10, a compound isolated from Parawixia bistriata spider venom (Araneidae: Araneae) in rats undergoing intrahippocampal NMDA microinjection.

Authors:  Helene Aparecida Fachim; Marcia Renata Mortari; Leonardo Gobbo-Netto; Wagner Ferreira Dos Santos
Journal:  Pharmacogn Mag       Date:  2015 Jul-Sep       Impact factor: 1.085

3.  The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.

Authors:  Genoveva Uzunova; Eric Hollander; Jason Shepherd
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

4.  SAD-B modulates epileptic seizure by regulating AMPA receptors in patients with temporal lobe epilepsy and in the PTZ-induced epileptic model.

Authors:  Rong Li; Miaoqing He; Bing Wu; Peng Zhang; Qinbin Zhang; Yangmei Chen
Journal:  Braz J Med Biol Res       Date:  2020-04-06       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.